Matinas BioPharma gets 2027 window to restore NYSE American listing compliance

Chinese EV maker BYD continues to make aggressive plans for Europe

2026/10/12

Jiuzi Holdings announces strategic investor commitment of $50M

2026/10/12

Harmony Biosciences appoints Peter Anastasiou as CEO

2026/10/12

Bausch + Lomb names Thomas Appio interim CEO, signals guidance hike

2026/10/12